Autumn Kujawa, Ph.D.

Autumn Kujawa, Ph.D.
Position

Associate Professor, Psychology and Human Development

Position

Director of the Mood, Emotion, & Development Lab

University

Vanderbilt University

Grant or Prize

2022, 2018 Young Investigator Grant

Autumn Kujawa, Ph.D. is an Associate Professor in Psychology and Human Development at Vanderbilt University and director of the Mood, Emotion, & Development Lab. She earned her Ph.D. from Stony Brook University and completed her clinical internship and postdoctoral fellowship in the neuroscience of mental health at the University of Illinois at Chicago. Dr. Kujawa's research aims to reduce the burden of mood disorders on youth and families. In particular, she examines how children and adolescents process and respond to emotion, how alterations in emotional processing contribute to the development of mood disorders, and how this knowledge can be translated to improve interventions. Dr. Kujawa has been recognized as a Rising Star by the Association for Psychological Science, received an Early Career Award from the Society for Psychophysiological Research, and has been awarded research funding from the National Institute of Mental Health, Brain and Behavior Research Foundation, Klingenstein Third Generation Foundation, and American Psychological Foundation.

Enhancing Positive Emotions to Prevent Depression in Youth

Treatment for depression traditionally focuses on reducing negative emotions like sadness or anger and less on increasing positive emotions like contentment and happiness. In this talk, Dr. Kujawa will first review research informed by neuroscience that highlights difficulties with positive emotions as a key risk factor for the development of depression in youth. Next, Dr. Kujawa will describe new approaches to intervention that aim to increase positive emotions in children and emerging adults to reduce depression risk across time.

Watch webinar recording:

Detection of Suicide-Related Emergencies Among Children Using Real-World Clinical Data

Suicide is a national and international public health priority, and suicidal behavior among children is common, costly, and preventable. Systematic, accurate, and equitable detection of children who present to medical care for suicidal thoughts and behaviors is challenging. In turn, suicide and self-harm prediction models and evidence-based personalized decision support tools to reduce suicide risk hold promise for prevention efforts, but are seldom adopted in clinical practice for children.

2023 Leading Research Achievements

Posted: December 28, 2023

We are pleased to present you with the 2023 Leading Research Achievements by BBRF Grantees, Prize Winners & Scientific Council Members.

Probing the Role of Impulsive Behaviors in Alcohol Misuse and Suicidality

Heavy drinking and the problematic use of alcohol are widely thought to be relevant factors in assessing an individual’s risk for suicidal behavior. It has been the role of research to investigate exactly how alcohol use and suicidality are related.  

Desmond J. Oathes

Desmond J. Oathes
Position

Associate Professor of Psychiatry

Position

Associate Director, Center for Neuromodulation in Depression and Stress

Position

Co-Director, Penn Brain Science, Translation, Innovation, and Modulation Center (brainSTIM)

Position

Staff Therapist, Penn Center for the Treatment and Study of Anxiety

Position

Director, Center for Brain Imaging and Stimulation

University

University of Pennsylvania

Grant or Prize

2016 Young Investigator Grant

Testing a New Way to Precisely Target and Predict the Impact of TMS Brain Stimulation for Depression

As non-invasive brain stimulation—variations of TMS (transcranial magnetic stimulation)—continues to evolve and is administered to a growing number of patients with depression (and other illnesses, including OCD), researchers seek to understand how and why it is able to help reduce symptoms in patients who respond positively.

Hengyi Cao, MB, Ph.D.

Hengyi Cao, MB, Ph.D.
Position

Assistant Professor, Institute of Behavioral Science

University

Feinstein Institutes for Medical Research

Grant or Prize

2018 Young Investigator Grant

Dr. Hengyi Cao is an assistant professor at the Feinstein Institutes for Medical Research and Zucker Hillside Hospital. He has been conducting neuroimaging research in psychiatry for more than 10 years and has extensive experience in psychiatric neuroimaging and clinical neuroscience. Dr. Cao has published more than 30 first-authored papers in leading journals and has served as a reviewer for more than 40 journals in the field. He has received awards from multiple research societies and foundations, including the Schizophrenia International Research Society, Society of Biological Psychiatry and the Brain and Behavior Research Foundation.

A Connectivity Signature Predicting Response to Antipsychotic Therapy is Identified in First-Episode Psychosis Patients

In people who experience a first psychotic episode—often the prelude to schizophrenia and related disorders—the individual’s response to antipsychotic medicines can be crucial, and typically, varies considerably from patient to patient.